Kaiser Permanente Data Provides Strong Evidence for Continued Value of Combined Pap and HPV Testing
... cancer with a primary known cause -- the human papillomavirus (HPV). QIAGEN developed and markets the digene ... In the study "Five-Year Experience of Human papillomavirus DNA and Papanicolaou Test Cotesting," Dr. Philip ... includes the leading FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer. ...Mexican Department of Public Health to Launch Screening for Papillomavirus, Cause of Cervical Cancer
... a program that will offer free testing for human papillomavirus (HPV), the primary cause of cervical cancer, to ... lowest-income 125 counties will be offered the papillomavirus test along with the traditional Pap smear. Early ... their income level or social class." papillomavirus is a very common infection. In fact, the World ...LSUHSC public health contributes to estimate of HPV-related cancers
... comprehensive assessment of the burden of human papillomavirus (HPV)-associated cancers in the United States to date. The report, "Assessing the Burden of Human papillomavirus (HPV)-Associated Cancers in the United States ... and monitoring the impact of prophylactic human papillomavirus vaccines: The potential role (p 3047-3057). ...Virus May Affect Survival in Head and Neck Cancer
... Human papillomavirus infection linked to better prognosis, research suggests THURSDAY, July 30 (HealthDay News) -- Infection with the human papillomavirus (HPV) may improve survival in patients with head and neck cancer, U.S. ...Low prevalence of HPV infection may be tied to poor prognosis for blacks with head and neck cancer
... found that head and neck cancer patients who test positive for the human papillomavirus (HPV) have much better survival rates than patients who don't have the ... our current treatments combining chemotherapy and radiation." The human papillomavirus is known to cause certain types of cancer and is a major risk factor for ...New Evidence Supports HPV Vaccine
... Industry-funded study showed high levels of protection against human papillomavirus MONDAY, July 6 (HealthDay News) -- The human papillomavirus (HPV) vaccine is highly effective at preventing precancerous cervical ...CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
... the two most common cervical cancer-causing human papillomavirus types for up to 6.4 years. This is the ... women were evaluated for the presence of human papillomavirus DNA by PCR using cervical samples and annual ... progression Approximately 100 types of human papillomavirus have been identified to date and, of these, ...Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
... of prevention and detection, including HPV testing and vaccination." Human papillomavirus (HPV) is the primary cause of cervical cancer, and QIAGEN has developed ... tests available worldwide, including the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer. QIAGEN employs more than ...Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
... International Journal of Cancer show that women screened only with a human papillomavirus (HPV) DNA test are half as likely to develop moderate to severe cervical ... tests available worldwide, including the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer. QIAGEN employs more than ...Hybrid Capture® 2 High-Risk HPV DNA Test®
Description:... An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68 in Cervical ....Human Papillomavirus (HPV) High Risk, Paraffin
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' ...Human Papillomavirus (HPV) Panel, Paraffin
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' ...Human Papillomavirus (HPV) Low Risk, Paraffin
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' ...Human Papillomavirus (HPV) DNA Probe, High Risk, Cervix
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' ...Subterfuge, counter-surveillance and assassination: The body's fight with cervical cancer
... for new treatments for the disease. Human papillomavirus (HPV), a virus which causes several types of ... Chief Executive, Elaine King commented: Human papillomavirus is extremely complex with many mechanisms ... help us to develop effective ways to combat Human papillomavirus in the future. ...More than half of Texas physicians do not always recommend HPV vaccine to girls
... - The Advisory Committee on Immunization Practices recommends the human papillomavirus vaccination for all 11- and 12-year-old girls, but results of a recent ... Cincinnati Children's Hospital Medical Center. The quadrivalent human papillomavirus (HPV) vaccine has been mired in controversy since it was approved in 2006. ...Iowa State researchers develop technology for early detection of viruses
... for Excellence at Iowa State. The project advanced just as human papillomavirus made national headlines. In June of 2006, the U.S. Food and Drug ... 26. The Centers for Disease Control and Prevention reports the human papillomavirus is the most common sexually transmitted infection in the U.S. The agency ...NIH funds $9.5 million for research on HIV and the human innate immune system
... as highly active anti-retroviral therapy (HAART) have increased the incidence of oral complications, such as a quadrupled rate of contracting human papillomavirus (HPV). This virus is more frequently associated with the genital tract and is now being seen in the mouth. Warts produced by HPV can lead to cancer ...Arbor Vita presents new data on cancer diagnostic at EUrogin
... test that was designed using AVC's PDZ discovery platform. This E6 strip test, now in development, detects the E6 oncoprotein produced by the human papillomavirus (HPV), the principal cause of cervical cancer. E6 is a diagnostic marker of high positive predictive value for cervical cancer because of its ...Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening
... a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers. In the study, researchers at Johns Hopkins University used oral rinses and targeted DNA amplification to ...Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
... -- Presented preclinical data at International papillomavirus conference demonstrating that ... the continued advancement of new HspE7 for human papillomavirus (HPV)-related diseases." Total Year 2007 and ... and cancerous lesions caused by the human papillomavirus (HPV), one of the most common sexually ...Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
... an agreement to exclusively license the Human papillomavirus (HPV) patent portfolio held by Quantovir AB of ... on HPVs presented at the 21st International papillomavirus Conference in Mexico City, 20-26 February 2004. papillomavirus Rep 2004;15:121-3. (3) Walboomers JM, ...Plexus Awarded Development Contract With QIAGEN
... next generation automated screening system for the pre-processing of human papillomavirus (HPV) DNA samples. This product provides a highly automated solution to a ... worldwide. This panel includes the first FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer. QIAGEN employs more than ...CERVARIX(R) U.S. Regulatory Update
... to prevent cervical cancer and cervical pre-cancer related to human papillomavirus types 16 and 18. GSK has submitted final data from its Phase III ... of high-grade pre-cancerous cervical lesions (CIN2+) caused by human papillomavirus types 16 or 18. Secondary objectives included evaluation of vaccine ...Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
... the timing of major R&D projects. These projects include assays for human papillomavirus (HPV) and healthcare-associated infections, a fully automated instrument ... ULTRIO assay in the United States, development of the APTIMA human papillomavirus assay, and development of the Panther instrument platform for low- ...